Cargando…
Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
We present a female patient in her early twenties with global development delay, progressive ataxia, epilepsy, and myoclonus caused by a stop mutation in the SEMA6B gene. Truncating DNA variants located in the last exon of SEMA6B have recently been identified as a cause of autosomal dominant progres...
Autores principales: | Herzog, Rebecca, Hellenbroich, Yorck, Brüggemann, Norbert, Lohmann, Katja, Grimmel, Mona, Haack, Tobias B., von Spiczak, Sarah, Münchau, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283161/ https://www.ncbi.nlm.nih.gov/pubmed/34092044 http://dx.doi.org/10.1002/acn3.51403 |
Ejemplares similares
-
Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019) -
Late-onset Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy with Myoclonus
por: Zhang, Xin-Yue, et al.
Publicado: (2016) -
Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015) -
Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes
por: Castellotti, Barbara, et al.
Publicado: (2023) -
Non-convulsive Status Epilepticus in SEMA6B-Related Progressive Myoclonic Epilepsy: A Case Report With Literature Review
por: Duan, Jing, et al.
Publicado: (2022)